Archive Newsletter

21. 05.29.25 -- Efficiently And Safely Manufacture Cell & Gene Therapies 5/29/2025
    05/29/25 Cell & Gene Newsletter
22. 05.29.25 -- Enhance Safety In Cell And Gene Therapies 5/29/2025

    05/29/25 Cell & Gene Newsletter

23. 05.29.25 -- Key Considerations For Early-Stage CGT Companies When Selecting A CDMO 5/29/2025
    05/29/25 Cell & Gene Newsletter
24. 05.28.25 -- Protecting Intellectual Property In The Genomics Revolution 5/28/2025
    05/28/25 Cell & Gene Newsletter
25. 05.27.25 -- Enhancing Safety And Speed In CGT Manufacturing: Assays, Plasmids, And More 5/27/2025

    05/27/25 Cell & Gene Newsletter

26. 05.27.25 -- STREAM Edition: Freezing Studies For Single-Use Solutions: Long-Term (Part 2) 5/27/2025
    05/27/25 Cell & Gene Newsletter
27. 05.27.25 -- Ferring Builds A Global Gene Therapy Manufacturing Network Around ADSTILADRIN 5/27/2025
    05/27/25 Cell & Gene Newsletter
28. 05.23.25 -- Accelerate Your Cell And Gene Therapy Research 5/23/2025
    05/23/25 Cell & Gene Newsletter
29. 05.23.25 -- Distributed Cell Therapy Manufacturing Trade-Offs You Should Know About 5/23/2025
    05/23/25 Cell & Gene Newsletter
30. 05.22.25 -- Hard Lessons In Parenteral Automatic Visual Inspection 5/22/2025
    05/22/25 Cell & Gene Newsletter